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From the Department 01 Urology， Osaka Medical College 
The process of chronic allograft nephropathy (CAN) is primarily concerned with disparity in 
m司orhistocompatibility. However， changes similar to CAN have been seen in human kidney 
transplants between identical twins， as well as in rat kidney isogra白s. Such changes cannot be 
eXplained by antigen-dependent factors; antigen-independent factors are likely to be involved in the 
onset of CAN. A CAN-type picture also was seen in a rat single kidney model subjected to ischemic 
injurγ， indicating the importance ofischemia in the process ofCAN. In the present study， CAN was 
accelerated by renal ablation in a rat kidney transplant model with reduced nephron number. 
Conversely， recipients with increased renal mass bearing two allografts， did not show any signs ofCAN. 
These observations suggested that a non-allogenic factor such as ischemia and insufficient nephron 
number is critical in the development ofCAN， and thus the etiology ofCAN is hypothesized as follows. 
Many factors such as ischemic lllJUry， acute rejection or infection reduce the functioning nephron 
number， which causes hyperfiltration in remaining nephrons leading to glomerulosclerosis. This in 
turn， further reduces the functioning nephron number. These progressive events may reinforce further 
the stimulus of hyperfiltration， thereby establishing a self二sustainingvicious cycle. Any factor 
preventing the reduction of functioning nephron number， can be a candidate for treatment. Herein 
we showed that treatment with hepatocyte growth factor (HGF)， a renotropic factor， in the initial 
disease stage prevented further development of CAN. 






























学的には，術後6，8， 12， 16， 24， 32週目に移植腎




IL-6， IL-lO， MCP-l， NOSi， RANTES， TGF幽s，

















































































て 1/3機能腎を作成できる.この 1/3機能腎を Lew
レシピエントに同所性に移植し， 1/3腎アログラフト
を作成.2)オリジナルの慢性拒絶反応モデル:(1ア
ログラフト) 1つの F344腎を両側腎摘した Lew
ラットに移植. 3)機能糸球体数増加モデル:(2アロ















A 150 -ーー-113A - -0- lA 










































































段として hepatocytegrowth factor (HGF)という肝
細胞増殖因子を腎移植後4週間静注投与することで慢
性拒絶反応の発症を著明に軽減することに成功し
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